- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Bristol Myers Squibb paves way for expansion of Camzyos to adolescent patients | ||
| Mo | AbbVie drops $175M on Ariz. drug-device plant as US investment tour rolls on | ||
| 09.01. | Putting patients first: from buzzword to business imperative | ||
| 09.01. | Athira Pharma roars into the new year with rebrand to LeonaBio | ||
| 09.01. | Orca rides $250M funding wave toward cancer cell therapy launch | ||
| 09.01. | J&J strikes MFN deal with Trump, reveals plan to build 2 US manufacturing sites | ||
| 09.01. | Insmed's 'blowout' Brinsupri sales beat fuels multi-blockbuster outlook | ||
| 09.01. | Novartis charts next US investment with plan for new radiopharma plant in Florida | ||
| 08.01. | Lilly touts promise of Zepbound-Taltz combo in patients with obesity and psoriatic arthritis | ||
| 08.01. | Vanda's shares drop after 2nd FDA rejection for Hetlioz in jet lag disorder | ||
| 08.01. | InflaRx to prune headcount by 30%, curb COVID drug spending in bid to advance new favorite asset izicopan | ||
| 08.01. | AstraZeneca taps Spain head Rick Suarez to lead US biopharma unit, head up $50B investment surge | ||
| 08.01. | Acuitas takes majority stake in Montreal-based RNA construct manufacturer | ||
| 08.01. | Novo Nordisk conducts a new conversation on weight stigma at major NYC commuter hub | ||
| 07.01. | Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication | ||
| 07.01. | FDA untitled letter skewers Esperion's claims about cholesterol med Nexlizet in TV ad | ||
| 07.01. | Daiichi taps Genesis to handle commercialization of leukemia med Vanflyta in 13 European countries | ||
| 07.01. | Viking enlists commercial chief to battle obesity giants, while Aspen names CCO to prep for Parkinson's launch | ||
| 07.01. | Lilly's prospective cardiometabolic launches dominate list of drugs to watch in 2026: Clarivate | ||
| 06.01. | Jazz touts Ziihera as the new HER2 agent of choice in stomach cancer | ||
| 06.01. | M+C Saatchi taps former Pfizer CMO Freda Lewis-Hall as 1st medical advisor | ||
| 06.01. | J&J's Tremfya outstrips AbbVie's Skyrizi again, closing out 2025 as December's top TV ad spender | ||
| 06.01. | 3 biopharma CEOs explain why they are 'authentically optimistic' for 2026 | ||
| 06.01. | AstraZeneca looks to grow reach in lupus with phase 3 win for self-administered Saphnelo | ||
| 05.01. | As Vyvgart empire expands, argenx CEO passes reins to operating chief Karen Massey |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .